Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study
Teng-Fei Chen,1 Zhan-Jiang Li,2 Hua-Si Zhao,1 Rui Yang2 1Department of Respiratory Medicine Ward 2, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People’s Republic of China; 2Department of Respiratory Medicine Ward 1, The First Affiliated Hospital of Zhengzhou University,...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/feasibility-and-safety-of-anlotinib-combined-with-immune-checkpoint-in-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|